Cancer Marker Suppliers Serving Eritrea

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...

AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...

Biozek medical is a Netherlands based manufacturer with wide ranges of IVD products, as a biotechnology company that specializes in research & development, manufacturing an distribution of the medical diagnostics and innovative immunodiagnostic ...

Incorporated in PA in 2011, our MISSION is to translate our circulating cell-free DNA (cfDNA) in urine technology into improved cancer screening and management by liquid biopsy towards our VISION of decreased global cancer mortality. Our proprietary ...

Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world. Vitrosens Biotechnology headquartered in Turkey, by a group of entrepreneurs with a ...

DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors. The German ...

BioMaxima S.A. is a Polish company listed on GPW Main Market, producer of microbiology media as well as a wide range of reagents and in vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics ...

A proven pioneer and partner to the diagnostics industry. Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby ...

ImevaX is a Biotech company based in Munich with a focus on facilitating H. pylori Diagnostics with a novel Rapid Diagnostic ...

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. We specialize in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests for laboratories, clinics, hospitals and ...

Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...

Cnpair Biotech Co., Ltd. is a professional provider which concentrates on IVD core materials, including antibodies and proteins, and we are dedicated to developing and delivering highly competitive antibodies and proteins with outstanding ...

EastCoast Bio has been a supplier of high quality antigens, antibodies, universal non-mammalian blocking reagents, and specialized immunoassay reagents for the in vitro diagnostic (IVD) manufacturing industry worldwide. Large and small manufacturers ...

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

We are pleased to announce the exclusive commercialization and sale of KinesisDx product lines to Krishgen Biosystems, India for worldwide usage effective July 11, 2019. This is in line with our philosophy to partner with forward looking companies ...

MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...

Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...

BiosPacific, Inc. was founded in 1989 as a supplier of immunological reagents to the commercial diagnostic industry. Our strength over the years has been to consistently meet the demands of this dynamic industry and our diverse customer base. Over ...

Since 2014, DiaSino Laboratories specialized in design, development, manufacture and worldwide distribution of Immunodiagnostic reagents, including three platforms: Porrima fully automatic chemiluminescence immunoassay, Infinosis fluorescent ...